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Summary
In addition to the tyrosines of the Iga and b immunore-
ceptor tyrosine-based activation motifs (ITAMs), the
evolutionarily conserved Iga non-ITAM tyrosine 204
becomes phosphorylated upon antigen recognition
by the B cell receptor (BCR). Here we demonstrate
that splenic B cells frommice with a targeted mutation
of Iga Y204 exhibited an isolated defect in T cell-inde-
pendent B cell activation, proliferation, and antibody
response upon BCR engagement, yet normal BCR
capping, antigen internalization, antigen presentation,
and T cell-dependent antibody production. Mutant B
cells, present in normal numbers, exhibited unim-
paired BCR-induced spleen tyrosine kinase (Syk)
phosphorylation but reduced B cell linker protein
(BLNK) phosphorylation, calcium flux, and nuclear
factor kB (NFkB), c-jun N-terminal kinase (JNK), and
extracellular signal-regulated kinase (ERK) activation.
These results suggest that Iga non-ITAM tyrosine 204
promotes a distinct cellular response, namely T-inde-
pendent B cell proliferation and differentiation via
phosphorylation of the adaptor BLNK.
Introduction
Antigen recognition by the B cell receptor (BCR) leads to
a multitude of cellular responses in mature B cells.
These responses include BCR cap formation, antigen in-
ternalization, T cell-independent B cell proliferation, and
antibody production, as well as antigen presentation
and the T cell-dependent antibody response. Experi-
ments in cell lines and mice have provided insights
into the proximal signaling requirements of the events
after BCR engagement. Cap formation and antigen in-
ternalization are promoted by Syk and Lyn, respectively
(Ma et al., 2001), which are among the first protein tyro-
sine kinases to be activated after BCR engagement
(Kurosaki, 1999). B cell proliferation and the generation
of the T-independent type II, but not the T-dependent
antibody response, depends upon the activation of
a specific set of proximal BCR signaling molecules (Fru-
man et al., 2000), many of which are phosphorylated by
Lyn tyrosine kinase (Lyn) and spleen tyrosine kinase
(Syk) (Kurosaki, 1999). These molecules, which include
Bruton’s tyrosine kinase (Btk), phospholipase Cg2
(PLCg2), and others, are thought to form a supramolecu-
lar complex upon BCR crosslinking, nucleated by the
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chusetts 02115.tyrosine phosphorylated form of the adaptor B cell linker
protein (BLNK, SLP-65, or BASH) (Chiu et al., 2002; Fu
et al., 1998; Wienands et al., 1998). This complex, also
termed B cell signalosome, connects the BCR with path-
ways implicated in cellular activation and proliferation
such as the calcium response and the nuclear factor
kB (NFkB) and mitogen-activated protein (MAP) kinase
pathways (Gugasyan et al., 2000; Ishiai et al., 1999; Kur-
osaki, 1999; Tan et al., 2001). Less is known about sig-
naling requirements downstream of the BCR for the
induction of antigen presentation to T cells and the
T cell-dependent antibody response, although Syk
may play a role in this respect (Lankar et al., 1998).
While it is established that the cytoplasmic domains of
the Iga-b heterodimer constitute the signal-transducing
units of the BCR, the mechanisms as to how the BCR ac-
tivates signaling pathways resulting in cap formation
and antigen internalization, B cell proliferation and
differentiation, or antigen presentation are less well un-
derstood. BCR signaling is thought to be initiated by
phosphorylation of tyrosines within the Iga and b immu-
noreceptor tyrosine-based activation motifs (ITAMs) by
binding and activating Syk and Lyn (Kurosaki, 1999), and
thus resembles signal transduction of many other
activating receptors of the immune system (Cambier,
1995). However, the BCR also becomes phosphorylated
at an evolutionarily conserved non-ITAM tyrosine resi-
due located at the tip of the Iga cytoplasmic domain in
position 204 (Kabak et al., 2002; Kraus et al., 2001), a fea-
ture that sets the BCR apart from other known ITAM-
containing receptors. Phosphorylated Iga Y204 has
been demonstrated to bind the C-terminal BLNK src-ho-
mology 2 (SH2) domain (Engels et al., 2001; Kabak et al.,
2002), raising the question of whether Y204 mediates re-
cruitment of membrane-associated BLNK to the site of
the BCR and pre-BCR to allow for its phosphorylation
by ITAM bound Syk (Kohler et al., 2005). Whether such
an interaction may be important for BLNK phosphoryla-
tion and the calcium response has been addressed in
experiments crosslinking fusion proteins of Iga and
platelet-derived growth factor receptor in cell lines,
which suggested a minor role of Iga Y204 in these re-
spects (Kabak et al., 2002). A more recent study demon-
strated that crosslinking fusion proteins of CD8 and Iga
with point mutation of Y204 in chicken DT40 cells re-
sulted in reduction of BLNK phosphorylation by 50%,
while no reduction was observed when cocrosslinking
fusion proteins of CD8 and Igb, suggesting that Iga
Y204 may not be required for BLNK phosphorylation in
the context of an Iga-b heterodimer (Pike and Ratcliffe,
2005). Other functions have been attributed to Iga
Y204 based on experiments expressing chimeric mole-
cules in cell lines, including a role in activation of MAP
kinase family members c-jun N-terminal kinase (JNK)
and extracellular signal-regulated kinase (ERK) as well
as antigen presentation (Kabak et al., 2002; Siemasko
et al., 2002). Whether these results represent findings
relevant in the context of a complete BCR in vivo re-
mains unclear. In addition to Iga Y204, a second non-
ITAM tyrosine is embedded in the human and murine,
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56Figure 1. Generation of Iga Non-ITAM Tyrosine Mutant Mice
(A) Amino acid sequence of the murine Iga cytoplasmic domain harboring non-ITAM tyrosine Iga Y204, highly conserved and phosphorylated
upon BCR crosslinking (Kabak et al., 2002), and Iga Y176, conserved in human and mouse, but not chicken, in addition to its ITAM tyrosines.
(B) IgaY204F/Y204F and IgaY176,204F/Y176,204F mice carry germline mutations in the Iga encoding mb-1 gene, resulting in expression of Iga protein
with Y204 replaced by phenylalanine, and with both Y176 and Y204 replaced by phenylalanine, respectively.but not chicken, Iga ITAM in position Y176, which re-
mains unphosphorylated upon BCR crosslinking (Kabak
et al., 2002). Iga Y176 has been suggested to synergize
with Iga Y204 to mediate BLNK phosphorylation and
the calcium response after crosslinking chimeric Iga
molecules (Kabak et al., 2002). As for the case of Iga
Y204, the role of Iga Y176 in the context of a complete
BCR in vivo has not been investigated.
In this study, we explored the in vivo function of Iga
Y204 alone and in combination with IgaY176 by employ-
ing a targeted mutagenesis approach in mice.
Results
Generation of Iga Non-ITAM Tyrosine Mutant Mice
By modifying a gene-targeting strategy previously em-
ployed (Kraus et al., 2001), we generated two mutant
mouse strains with point mutations in the Iga-encoding
mb-1 gene resulting in replacement of the codons for
Y204, or Y204 and Y176 by phenylalanine codons (Fig-
ure 1, see Figure S1 in the Supplemental Data available
with this article online). The correct integration of the
mutantmb-1 gene into the mouse germline was ensured
by Southern blotting, PCR, and DNA sequencing
(Figure S1, and data not shown). The mutant alleles
were termed IgaY204F and IgaY176,204F, respectively,
and mice homozygous for these alleles were analyzed.
Because of the similarity in phenotype of IgaY204F/Y204F
and IgaY176,204F/Y176,204F mice, we concentrated our
efforts on the analysis of IgaY204F/Y204F mice and report
results from IgaY176,204F/Y176,204F mice in the last para-
graph of the Results.
Iga Y204 Is Not Essential for Follicular and Marginal
Zone BCell Development but Is Required for B1a Cell
Development
Flow cytometric analysis of the bone marrow, spleen,
and peritoneal lavage did not show any indication of
compromised follicular and marginal zone B cell devel-
opment but did reveal strongly reduced B1a cell num-
bers in IgaY204F/Y204F mice (Figure 2). Specifically, none
of the B cell subsets in the bone marrow (Hardy and Hay-
akawa, 2001) was reduced in size in 10-week-old mice
(n = 6, Figure 2A). Similarly, young mice did not show
an apparent defect in B cell development as evidencedby normal bone marrow cellularity and splenic B cell
numbers in 5-week-old mice (n = 2, data not shown).
Furthermore, follicular and marginal zone B cell num-
bers in the spleen were normal (Figure 2B). They showed
all characteristics of fully mature, resting B cells as
judged by the expression levels of CD19, B220, CD23,
AA4.1, CD1d, CD21 (n > 6), BAFF-R, CD40 (n = 3), as
well as CD69, MHC Class II, and CD22 (n = 2) (Figure 2B,
and data not shown; Allman et al., 2001; Hardy and Hay-
akawa, 2001; Martin and Kearney, 2002). Surface ex-
pression of IgM and IgD, frequently elevated in mice de-
ficient in BCR-signaling molecules, was also normal
(Figure S2). Another characteristic of mature B cells is
their longevity (Forster and Rajewsky, 1990), which
IgaY204F/Y204F B cells shared with their wild-type coun-
terpart as determined by a bromodeoxyuridine (BrdU)
labeling experiment (Figure S2). In contrast to follicular
and marginal zone B cell numbers, splenic B1 cell num-
bers were strongly decreased (Figure 2B). Similarly, the
fraction of B1a cells in the peritoneal lavage of 10- to 12-
week-old IgaY204F/Y204F mice was reduced to approxi-
mately 1/5 of that seen in wild-type mice (Figure 2C).
In addition, the size of fraction F in the bone marrow
was doubled in IgaY204F/Y204F mice (Figure 2A), and
splenic transitional AA4.1+ B cell numbers were in-
creased by approximately 40%, an enlargement to
which subpopulations T1, T2, and T3 contributed to
a similar extent (Figure 2B, and data not shown). We
conclude that Iga Y204 is not essential for the develop-
ment of marginal zone and follicular B cells, but is re-
quired for B1a cell development.
Iga Y204 Promotes B Cell Activation and
Proliferation In Vitro
Crosslinking of the BCR with bivalent anti-IgM F(ab)2
fragments (anti-IgM) as a surrogate antigen in vitro in-
duces T cell-independent B cell activation and moderate
B cell proliferation of follicular, but not immature, B1 or
marginal zone B cells (Martin and Kearney, 2002). Cul-
turing of purified splenic B cells in the presence of
anti-IgM revealed that IgaY204F/Y204F B cells exhibited
defects in B cell activation, cell cycle entry, and pro-
liferation (Figure 3). Specifically, the proportion of
IgaY204F/Y204F B cells that upregulated the activation
marker CD69 was decreased in comparison to wild-type
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57Figure 2. Reduction in B1 Cells, but Not Fol-
licular and Marginal Zone B Cells in
IgaY204F/Y204F Mice
Flow cytometric analysis of bone marrow (A),
spleen (B), and peritoneal lavage (C) from
adult IgaY204F/Y204F mice.
(A) Bone marrow B cell subsets shown as %
of lymphocytes (top) and % of IgM2 lympho-
cytes (middle) and bone marrow fractions A–
F (Hardy and Hayakawa, 2001) as % of total
bone marrow cells in 10-week-old mice (bot-
tom, n = 6; fraction D: p = 0.02, fraction F: p =
0.00001).
(B) Splenic B cells and B1 cells shown as % of
lymphocytes (top), marginal zone B cells as
% of CD19+ splenic B cells (second from
top), and mature and transitional B cells in
the spleen as % of lymphocytes (second
from bottom). Absolute numbers of transi-
tional B cells (B220+ AA4.1+ lymphocytes),
follicular B cells (B220+ AA4.12 CD23+ lym-
phocytes), marginal zone B cells (CD19+
CD21++ CD23low CD1d++ lymphocytes), and
B1 cells (CD19+ B220low CD5+ lymphocytes)
in the spleen given for 10-week-old mice (bot-
tom; n = 6; T1-T3: p = 0.09, B1: p = 0.00002).
(C) Peritoneal B1a, B1b, and B2 cells as % of
CD19+ lymphocytes (upper) and proportion
of B2 cells (CD19+ CD432 CD52 lympho-
cytes), B1a cells (CD19+ CD43+ CD5+ lym-
phocytes), and B1b cells (CD19+ CD43+
CD52 lymphocytes) in the peritoneal lavage
of 10- to 12-week-old mice given as % of total
peritoneal cells (lower; n = 3–4, B1a: p =
0.00013).
Closed circles denote results from individual
mice; bars represent the mean of values ob-
tained from several mice. p values were de-
termined by Student’s t test. Results were
confirmed in two additional experiments
with a total of 4–6 adult mice.controls after culture in the presence of 1, 5, and 10 mg/
ml anti-IgM for 16 hr and resembled in that respect the
behavior of Xid B cells analyzed under the same condi-
tions (Figure 3A, Figure S4, and data not shown).
IgaY204F/Y204F B cells also showed a defect in BAFF-R
upregulation, which is thought to represent one of the
survival-promoting events after BCR crosslinking
(Figure S2; Smith and Cancro, 2003). Consistent with
these results, blast formation of IgaY204F/Y204F B cells
as judged by forward scatter as well as the formation
of B cell aggregates were impaired after 36 hr of in vitro
culture with 1, 5, and 10 mg/ml anti-IgM (Figure 3A, and
data not shown). Furthermore, cell-cycle entry was de-
fective in IgaY204F/Y204F B cells compared to controls
as indicated by the reduced fraction of B cells found in
the S/G2/M phases of the cell cycle after stimulation
with 5 and 10 mg/ml anti-IgM for 36 hr and 40 hr, time
points at which B cells had not yet divided (Figure 3B,
and data not shown). Addition of stimuli such as BAFF,
IL-4, and CD40L surrogate antibody that promote B
cell survival and enhance BCR-induced proliferation re-
sulted in a variable increase of the percentage of
IgaY204F/Y204F B cells found in S/G2/M compared to
anti-IgM alone but did not reach the levels seen in
wild-type controls (Figure 3B). After 72 hr of culture
with anti-IgM, recovery of live IgaY204F/Y204F B cells
was as low as 10% of wild-type controls at the dosestested, and approximated the recovery typical for un-
treated wild-type and IgaY204F/Y204F B cells (Figure 3C).
In that time frame, wild-type B cells had undergone
one or two cell divisions as judged by the loss of carboxy-
fluorescein succinimidyl ester (CFSE), whereas the ma-
jority of the few IgaY204F/Y204F B cells remaining had
not divided when cultured in the presence of 10 mg/ml
anti-IgM (Figure 3C). After 4 and 5 days of anti-IgM stim-
ulation, the majority of IgaY204F/Y204F and wild-type B
cells found in the cultures had divided as suggested
by loss of CFSE, but mutant B cells were strongly re-
duced in number and lagged behind by on average
one cell division compared to controls (data not shown).
BCR crosslinking induces apoptosis in immature B cells
within the first day of in vitro culture (King and Monroe,
2000). To assess to what extent BCR-induced apoptosis
contributes to the decreased survival of anti-IgM-stimu-
lated IgaY204F/Y204F splenic B cells, the percentage of live
B cells after 24 hr of culture in the presence and absence
of 10 mg/ml anti-IgM was determined, but no differences
were found in wild-type and IgaY204F/Y204F B cell cultures
(Figure 3D). Likewise, viability of resting B cells in cul-
ture, another potentially contributing factor to de-
creased survival in anti-IgM-treated IgaY204F/Y204F B
cells, was normal after 24, 48, and 72 hr (Figure 3D,
and data not shown). The response of IgaY204F/Y204F B
cells to other T-independent nonspecific B cell mitogens
Immunity
58Figure 3. Defective BCR-Induced B Cell Activation, Cell-Cycle Entry and Proliferation In Vitro, and Impaired T-Independent Plasmablast Produc-
tion and Ig Secretion In Vivo in IgaY204F/Y204F Mice
(A) B cell activation as judged by surface CD69 expression (top) and blast formation (bottom) after culture in the presence of 10 mg/ml anti-IgM for
16 and 36 hr, respectively.
(B) Entry into S/G2/M phases of the cell cycle as determined by DNA staining of B cells with propidium iodide. Cells were cultured for 36 hr with
and without 10 mg/ml (1) and 5 mg/ml (2) anti-IgM, and in the presence or absence of 10 mg/ml anti-IgM combined with BAFF (0.2 mg/ml), anti-CD40
(2 mg/ml), or IL-4 (12.5 U/ml), as well as with LPS (20 mg/ml) or CpG-DNA (0.1 mM) alone.
(C) Cell divisions and recovery of live B cells after 72 hr of culture with 10 mg/ml anti-IgM (top) and as indicated (bottom), as suggested by the loss
of CFSE and the apoptotic cell marker TO-PRO-3.
(D) BCR-induced apoptosis and viability of purified IgaY204F/Y204F splenic B cells after culture for 24 hr with and without 10 mg/ml anti-IgM as de-
termined by propidium iodide staining.
(E) Generation of NP-specific IgM-secreting plasmablasts and NP-specific serum IgG3 titers in 8- to 12-week-old mice immunized with NP40-
Ficoll. Spleens were analyzed for the presence of NP-specific IgM-secreting antibody-forming cells (AFCs) 4 days after immunization with
25 mg NP-Ficoll by ELIspot assay (top, day 4: p = 0.009, as determined by Student’s t test). Closed circles represent means of NP-specific
IgM-secreting cell numbers per 106 splenic cells of duplicate ELIspot wells for individual mice, and bars geometric means of values obtained
from several mice (n = 4). Sera were analyzed by ELISA 7, 14, and 21 days after immunization with 10 mg NP-Ficoll for NP-specific IgG3 (bottom).
Shown are results for individual mice (n = 6) and geometric means, with mice lacking a measurable response depicted at the detection limit of the
assay (day 7, p = 0.008; day 14, p = 0.001; day 21, p = 0.002, as determined by Student’s t test).
All results shown are representative of two to four independent experiments.
BCR Signaling via Iga Non-ITAM Tyrosines
59including lipopolysaccharide (LPS) and CpG DNA was
also tested by assessment of cell-cycle entry and prolif-
eration, but no differences were detected (Figure 3B,
and data not shown). Taken together, these results
suggest that Iga Y204 lowers the threshold of splenic
B cells to respond with upregulation of activation
markers CD69 and BAFF-R, blast formation, cell-cycle
entry, and cell division upon BCR crosslinking. How-
ever, Iga Y204 has no essential role for the in vitro
survival of resting B cells and B cell apoptosis induced
by anti-IgM.
Iga Y204 Promotes T-Independent Plasmablast
Production and Antibody Response In Vivo
The TI-II antigen NP-Ficoll induces proliferation and dif-
ferentiation of NP-specific splenic B2 cells (Forster and
Rajewsky, 1987; Garcia de Vinuesa et al., 1999), thus re-
sembling the in vitro response of the cells to BCR cross-
linking. 4 to 5 days after immunization, the numbers of
NP-specific IgM-secreting antibody-forming cells
(AFCs) peak (Garcia de Vinuesa et al., 1999). 4 days after
intraperitoneal immunization of 8-week-old IgaY204F/
Y204F and control mice with NP-Ficoll, the numbers of
NP-specific IgM-secreting AFCs were reduced to ap-
proximately 30% of wild-type controls (Figure 3E). In
the course of a TI-II response, isotype switching to
IgG3 and IgG2a can be observed, which appears to be
dependent on the presence of cytokines in the environ-
ment (Garcia de Vinuesa et al., 1999; Mond et al., 1995).
Consistent with the observed impaired production of
NP-specific IgM-secreting AFCs in IgaY204F/Y204F mice,
we found a reduction in NP-specific serum IgG3 titers
in response to 10 mg NP40-Ficoll in the mutant mice to
approximately 25% of controls after 7, 14, and 21 days
(Figure 3E). Immunization of mice with increasing doses
of NP190-Ficoll showed that differences in NP-specific
serum IgG3 titers between IgaY204F/Y204F and control
mice were most pronounced at low doses and disap-
peared at higher doses of NP-Ficoll (Figure S2). In line
with a defective TI-II response, serum IgM, IgG2a, and
IgG3 titers in unimmunized 8-week-old IgaY204F/Y204F
mice were as low as 50% compared to wild-type mice
(Figure S2). These results suggest that Iga Y204 pro-
motes B cell differentiation to antibody-secreting plas-
mablasts in response to TI-II antigens in vivo but is not
absolutely required for this type of B cell response.
Iga Y204 Is Not Required for Antigen Presentation
and the T-Dependent Antibody Response
Upon antigen recognition by the BCR, protein antigen is
captured and degraded, and peptides bound to MHC
Class II are subsequently presented to T cells, resulting
in their activation (Clark et al., 2004). Specific TCR-pep-
tide-MHC Class II interactions in conjunction with costi-
mulatory signals initiate the T cell-dependent B cell re-
sponse (Bishop and Hostager, 2001). We tested
whether Iga Y204 contributes to antigen presentation
by culturing purified hen egg lysozyme-specific BCR
transgenic (IgHEL) B cells homozygous for the IgaY204F
allele for 24 hr in the presence of various concentrations
of hen egg lysozyme (HEL), and T cell hybridoma cells
expressing a HEL peptide-specific TCR. Interleukin 2
(IL-2) production by T cells was measured as an indica-
tor for TCR-induced T cell activation. No differences be-tween IgaY204F/Y204F IgHEL and IgHEL control B cells
were detected (Figure 4A). In order to assess the re-
sponsiveness of IgaY204F/Y204F B cells to T cell-derived
costimulatory signals, we stimulated purified B cells
with agonistic CD40 antibody combined with IL-4.
Again, no differences between the proliferative re-
sponses of IgaY204F/Y204F and control B cells were found
(data not shown). The specific antibody response to the
TD antigen NP-CGG was determined by immunization of
8-week-old mice with 5 mg and 50 mg of NP-CGG. No sta-
tistically significant differences in NP-specific IgG1 titers
7, 14, and 21 days after immunization with either dose
were detected (Figure 4B). In line with the absence of
an apparent defect in the T-dependent response, serum
IgG1 titers in unimmunized mice were normal
(Figure S2). We conclude that Iga Y204 has no essential
role in antigen presentation and the T-dependent anti-
body response.
IgaY204 HasNoEssential Role in Cap Formation and
BCR Internalization
An early event after antigen encounter by a B cell is the
polarization of BCR bound antigen to one end of the cell,
where localized signaling activity occurs, followed by
antigen internalization and attenuation of BCR signaling
(Thyagarajan et al., 2003). Stimulation of IgaY204F/Y204F B
cells with anti-IgM revealed that the percentage of cells
polarizing their surface IgM, imposing as cap-like struc-
tures, and its kinetics were normal compared to wild-
type controls (Figure 4C). Similarly, the kinetics of the
disappearance of surface bound anti-IgM after various
times of incubation with 10 mg anti-IgM/106 splenic cells
were similar in IgaY204F/Y204F and wild-type B cells
(Figure 4D). These experiments suggest that Iga Y204
is not required for polarization of antigen-BCR com-
plexes and their subsequent internalization.
Iga Y204 Promotes BLNK Phosphorylation and the
Calcium Response, but Not Syk Phosphorylation
BCR crosslinking on mature B cells results in rapid
phosphorylation of Iga and b ITAM tyrosines and binding
and activating of src-family kinases and tyrosine kinase
Syk, which in turn are thought to phosphorylate other
signal transduction molecules (Kurosaki, 1999). Immu-
noblotting of anti-IgM-stimulated B cells revealed an al-
tered protein tyrosine phosphorylation pattern in
IgaY204F/Y204F B cells compared to controls (Figure 5A,
Figure S3). Some unidentified tyrosine phosphorylated
protein bands were present only in wild-type, others
only in IgaY204F/Y204F lysates (Figure 5A, arrows,
Figure S3 for long exposure). Furthermore, several sub-
strates were hyperphosphorylated in the mutants at
early time points. In line with earlier observations indi-
cating that Iga non-ITAM Y204 becomes phosphory-
lated after BCR crosslinking (Kabak et al., 2002), total
Iga tyrosine phosphorylation in anti-IgM-stimulated
IgaY204F/Y204F B cells was reduced compared to con-
trols. Activation of Syk, the kinase demonstrated to
phosphorylate BLNK (Fu et al., 1998) was increased at
early and unaltered at late time points in anti-IgM-stim-
ulated IgaY204F/Y204F B cells compared to controls as
suggested by phosphorylation of Y525 and 526, located
in the activation loop of Syk and required for its activa-
tion (Figure 5B; Kurosaki et al., 1995). However, BLNK
Immunity
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(A) Purified IgaY204F/Y204F IgHEL and IgHEL B cells were cultured in triplicates in the presence of HEL at indicated concentrations and a HEL
peptide-specific TCR-expressing T cell line for 24 hr. IL-2 production by T cells was measured by ELISA. Closed circles represent means of trip-
licates performed for individual mice; bars represent the mean of results from two mice each. Results shown are representative of three inde-
pendent experiments.
(B) T-dependent antibody responses assessed by immunizing IgaY204F/Y204F and control mice with 5 and 50 mg NP-CGG, and determining NP-
specific serum IgG1 levels by ELISA after 7, 14, and 21 days (n = 4–5).
(C) Cap formation after BCR crosslinking with 10 mg/106 cells anti-IgM was examined by immunofluorescence microscopy. Examples of capped
B cells are shown in the left panel, and the kinetics and percentage of B cells that polarized IgM to 1/3 to 1/4 of the cell circumference are depicted
in the right panel. Results shown were confirmed in two additional independent experiments.
(D) The kinetics of surface IgM downregulation was assessed by incubating splenic B cells with 10 mg/106 cells anti-IgM containing a fraction of
biotinylated anti-IgM for the indicated times, followed by immediate fixation with nonpermeabilizing formaldehyde solution. Surface bound anti-
IgM was visualized with a streptavidin conjugate. Results are representative of three independent experiments.phosphorylation at several functionally important tyro-
sines, specifically BLNK Y72, a Vav and Nck binding
site, BLNK Y84, a PLCg2 binding site, and BLNK Y96,
a Btk binding site, was strongly decreased (Figure 5C;
Chiu et al., 2002). Furthermore, we observed a moderate
reduction in the BCR-induced calcium response in
IgaY204F/Y204F B cells upon stimulation with 20 mg/ml
anti-IgM employing the calcium-sensitive dye Indo-1
(Figure 5E). However, no reproducible differences in
phosphorylation of PLCg2 and Btk tyrosine residues,
essential for activation of the enzymes, were detected(Figure 5D). We conclude that Iga Y204 is essential for
BCR-induced BLNK phosphorylation, contributes to
the calcium response, and promotes a distinct protein
tyrosine phosphorylation pattern, but is not required
for tyrosine phosphorylation of Syk and the majority of
proteins phosphorylated upon BCR crosslinking.
Iga Y204 Promotes NFkB, JNK, and ERK Activation
BCR crosslinking in mature B cells results in engage-
ment of multiple pathways including the canonical path-
way of NFkB activation, as well as the activation of
BCR Signaling via Iga Non-ITAM Tyrosines
61Figure 5. Unimpaired Syk Phosphorylation, but Decreased BLNK Phosphorylation and Calcium Flux, and Distinct Protein Tyrosine Phosphory-
lation Pattern in IgaY204F/Y204F Splenic B Cells after BCR Crosslinking
(A–D) Immunoblotting of whole-cell lysates prepared from purified splenic B cells stimulated with 10 mg/106 cells anti-IgM for indicated time
points. Protein lysates were separated by 10% SDS-PAGE and blotted for total protein tyrosine phosphorylation (4G10 mAB), Iga and b-actin
(A), Syk pY525 and 526 present in Syk fractions with lower electrophoretic mobility (arrows, [B]), BLNK pY72, pY84, pY96, and BLNK (C), and
Btk pY223, Btk, PLCg2 pY1217, and PLCg2 (D). The tyrosine phosphorylated band of the size of Iga (arrow, [A]) corresponds to phosphorylated
Iga as suggested by its selective near complete absence in whole-cell lysates of anti-IgM-stimulated Iga ITAM tyrosine mutant B cells (Kraus
et al., 2001). Arrows (A) denote differentially tyrosine phosphorylated bands (compare Figure S3 for long exposure).
(E) Calcium flux after addition of anti-IgM (20 mg/ml final concentration) to splenic B cells labeled with the calcium-sensitive dye Indo-1 and de-
picted as 2% probability contour plots of the 405/485 nm emission ratio.
All results shown are representative of two to five independent experiments.MAP kinase family members JNK and ERK (Gugasyan
et al., 2000; Kurosaki, 1999). Our experiments suggest
that Iga Y204 promotes activation of each of these
pathways. Specifically, IgaY204F/Y204F B cells showed
a 30%–60% decrease in BCR-induced IkBa phosphory-
lation at serine residues 32 and 36 and impaired
degradation of IkBa, a molecular event initiating nuclear
translocation of NFkB family members (Figure 6A; Karin
and Ben-Neriah, 2000). Furthermore, JNK and also
ERK phosphorylation was decreased by 30%–50%
upon BCR engagement in IgaY204F/Y204F B cells com-
pared to controls as judged by immunoblotting and
quantification of signal intensities (Figure 6B, and data
not shown).Iga Y176 Does Not Synergize with Iga Y204 in B Cell
Development and Function
Analysis of IgaY176,204F/Y176,204F mice under the same
conditions as IgaY204F/Y204F mice revealed that features
of the phenotype observed in IgaY204F/Y204F mice
were not or to a minor degree enhanced in
IgaY176,204F/Y176,204F mice, contrary to predictions from
cell line studies indicating that Iga Y204 synergizes
with Y176 to promote BLNK phosphorylation and the
calcium response (Kabak et al., 2002). B cell develop-
ment, BrdU incorporation rate and survival of follicular
B cells, B cell activation, cell-cycle entry and prolifera-
tion in response to BCR crosslinking in vitro, antigen-
specific plasmablast production and IgG3 secretion in
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in response to NP-CGG, BCR-induced calcium flux,
and general tyrosine phosphorylation of anti-IgM-stimu-
lated whole B cell lysates of IgaY176,204F/Y176,204F mice
were analyzed as described in the respective sections
for IgaY204F/Y204F mice (Figure S4, and data not shown).
Consistent with phosphopeptide-mapping studies sug-
gesting that Iga Y176 remains unphosphorylated after
BCR crosslinking (Kabak et al., 2002), Iga tyrosine phos-
phorylation was not reduced to a greater extent than
observed in IgaY204F/Y204F mice as determined by quan-
tification of tyrosine phosphorylated bands of the size of
Iga (data not shown). We conclude that Iga Y176 does
not synergize with Iga Y204 in B cell development and
function in a physiologically relevant manner.
Discussion
The BCR is unique among multichain immune recogni-
tion receptors in that it is equipped, apart from its Iga
and b ITAM tyrosines, with an additional evolutionarily
conserved tyrosine phosphorylation site in the Iga cyto-
plasmic domain, Iga Y204. In this study, we delineated
previously unknown functions of Iga Y204 employing
a targeted mutagenesis approach in mice. Our results
suggest that phosphorylation of Iga Y204 in mature B
cells specifically promotes T-independent B cell activa-
tion, proliferation, and antibody response, as evidenced
by impaired BCR-induced IkBa phosphorylation and
degradation, JNK and ERK phosphorylation, B cell blast
formation, cell-cycle entry, and proliferation in vitro and
T-independent plasmablast production in vivo in
Figure 6. Impaired IkBa Phosphorylation and Degradation and De-
creased JNK and ERK Phosphorylation in BCR-Stimulated
IgaY204F/Y204F B Cells
Immunoblotting of whole-cell lysates prepared from purified splenic
B cells stimulated with 10 mg/106 cells anti-IgM for indicated time
points. Reduced protein lysates were separated by 10% SDS-
PAGE and blotted for IkBa pS32 and 36, IkBa, and b-actin (A), JNK
pT183 and pY185 and JNK, as well as ERK pT202 and pY204 and
ERK (B). Results shown are representative of two to four indepen-
dent experiments.IgaY204F/Y204F mice. However, Iga Y204 does not detect-
ably affect other cellular responses observed after BCR
engagement such as cap formation, BCR internaliza-
tion, antigen presentation, and the T-dependent im-
mune response. Earlier results in cell lines indicating
a critical role of Iga Y204 in antigen presentation may
therefore reflect a function of Iga Y204 that is not essen-
tial in an in vivo setting (Siemasko et al., 2002). The BCR
thus presents itself as an immune receptor that utilizes
ITAMs for protein tyrosine kinase activation and also
promotes a distinct cellular response through a non-
ITAM tyrosine in the Iga cytoplasmic domain.
Phosphorylated Iga Y204 was demonstrated to bind
the C-terminal SH2 domain of BLNK (Engels et al.,
2001; Kabak et al., 2002). This finding raised the ques-
tion of whether such an interaction may be important
to recruit membrane-associated BLNK to the BCR and
pre-BCR leading to BLNK phosphorylation by Syk and
allowing BLNK to function in its role as adaptor that as-
sociates with proximal BCR signaling molecules largely
via its phosphorylated tyrosine residues (Chiu et al.,
2002; Fu et al., 1998; Kohler et al., 2005; Wienands
et al., 1998). One earlier study indicated that Iga Y204
plays a minor role in BLNK phosphorylation based on
expressing Iga Y204 mutant chimeric molecules in cell
lines (Kabak et al., 2002), while experiments coexpress-
ing Iga and Igb chimeric molecules in chicken DT40 cells
suggested that IgaY204 contributes to BLNK phosphor-
ylation when crosslinking Iga alone, but not when coc-
rosslinking Igb (Pike and Ratcliffe, 2005). The present
experiments demonstrated that BLNK phosphorylation
at several functionally important tyrosine residues was
strongly decreased in splenic IgaY204F/Y204F B cells
upon crosslinking of the BCR, expressed at normal
levels. This may indeed be due to a disrupted interaction
between phosphorylated Iga Y204 and membrane
bound BLNK in the mutant B cells as several findings
suggest. Syk activation in BCR-engaged IgaY204F/Y204F
B cells was not impaired, indicating, in conjunction
with earlier reports demonstrating that active Syk local-
izes to the BCR and specifically to its ITAMs (Kurosaki,
1999; Ma et al., 2001), that in IgaY204F/Y204F B cells, active
Syk likewise localizes to the BCR upon crosslinking.
Since Syk represents the critical kinase to phosphory-
late BLNK (Fu et al., 1998), decreased BLNK phosphor-
ylation in IgaY204F/Y204F B cells thus suggests that trans-
location of BLNK into the proximity of active Syk was
impaired.
BLNK function was suggested to largely depend on
the phosphorylation status of its tyrosine residues in
chicken DT40 cells and pre-B cell lines (Chiu et al.,
2002; Jumaa et al., 2003), predicting a phenotype in
IgaY204F/Y204F B cells similar to that in BLNK-deficient
mice. IgaY204F/Y204F B cells share indeed numerous char-
acteristics with splenic B cells from BLNK-deficient
mice, ranging from an impaired BCR-induced calcium
response, NFkB activation, B cell proliferation, and T-in-
dependent antibody response to an unaltered T-depen-
dent response (Jumaa et al., 1999; Pappu et al., 1999;
Tan et al., 2001; Xu et al., 2000). We also observed a de-
crease in BCR-induced JNK and, less so, ERK phos-
phorylation in IgaY204F/Y204F B cells, a finding reported
earlier for Iga Y204 mutant chimeric molecules cross-
linked in cell lines and BLNK-deficient chicken DT40
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bak et al., 2002; Tan et al., 2001). However, the discrep-
ancy between BLNK-deficient DT40 cells and BLNK-de-
ficient mice may well be due to elevated expression
levels of IgM reported for the B cells in those animals
(Jumaa et al., 1999). This could result in stronger stimu-
lation of the cells upon IgM crosslinking and thus mask
an existing defect in JNK and ERK phosphorylation.
Taken together, the available experimental evidence is
thus in line with the notion that the key function of Iga
Y204 in mature B cells is to recruit BLNK to the BCR,
thus allowing for BLNK phosphorylation by Syk, which
in turn promotes NFkB, JNK, and ERK activation,
T-independent B cell proliferation, and the antibody
response.
Although not analyzed in parallel, defects detected in
splenic B cells from IgaY204F/Y204F mice appeared less
pronounced than reported for BLNK-deficient mice in
many respects. Furthermore, some characteristics of
BLNK-deficient mice were not found in IgaY204F/Y204F
mice. Specifically, resting B cells from BLNK-deficient
mice showed impaired in vitro survival, suggesting that
BLNK may be part of a signal transduction machinery
mediating a constitutive signal emanating from the
Iga-b heterodimer (Kraus et al., 2004; Tan et al., 2001).
However, IgaY204F/Y204F B cells exhibited unimpaired
in vitro and in vivo survival, indicating that Iga Y204
may not play a role in this context. Furthermore, while
displaying, similar to BLNK-deficient mice, a strong re-
duction in B1a cell numbers, IgaY204F/Y204F mice did
not show a developmental defect at the transition from
the pro- to the pre-B cell stage as seen in BLNK-defi-
cient mice (Jumaa et al., 1999; Pappu et al., 1999; Xu
et al., 2000). These findings thus suggest that BLNK
also functions in an Iga Y204-independent manner.
One possibility is that direct binding of BLNK to ITAM
bound active Syk mediates Iga Y204-independent re-
cruitment of BLNK to the BCR and the pre-BCR as pre-
viously discussed (Kurosaki, 2002). Such a mechanism
of BLNK recruitment may play a larger role at the pre-
BCR level than in BCR-engaged mature B cells as the
absence of a defect at the pro- to pre-B cell transition
in IgaY204F/Y204F mice might suggest, and is perhaps pro-
moted by the higher expression levels of BLNK at the
early B cell stages (Pappu et al., 1999). Iga non-ITAM
tyrosine 176 could also contribute to Iga Y204-indepen-
dent recruitment of BLNK, as earlier suggested by
Kabak et al. (2002). However, the findings presented
here argue against this possibility because of the similar
phenotypes of IgaY176,204F/Y176,204F and IgaY204F/Y204F
mice. Finally, BLNK, with its many protein binding
domains (Kohler et al., 2005; Kurosaki, 2002), may exert
an adaptor function independent of its tyrosine phos-
phorylation status, as suggested by the observation
that impairment of BCR-induced JNK and ERK phos-
phorylation was less pronounced in BLNK-deficient DT40
cells reconstituted with tyrosine mutant BLNK com-
pared to BLNK-deficient control cells (Chiu et al., 2002).
The present study defines IgaY204 as a critical residue
that connects the BCR to the adaptor protein BLNK,
a component of the BCR-associated ‘‘signalosome,’’
which transduces signals that result in T cell-indepen-
dent B cell activation, proliferation, and antibody re-
sponse (Fruman et al., 2000). In humans, null mutationsof BLNK result in a severe B cell deficiency that exceeds
in severity the phenotype of BLNK-deficient mice (Jumaa
et al., 1999; Minegishi et al., 1999; Pappu et al., 1999). It
will be interesting to see whether mutations of Iga Y204
similarly produce an immunodeficiency in humans with
perhaps stronger defects than in mice.
Experimental Procedures
Mice
Gene targeting was conducted according to protocols established
in the laboratory (Kraus et al., 2001). Chimeric mice were generated
through injection of targeted embryonic stem cells of the C57BL/6
background into Balb/C blastocycsts (Kontgen et al., 1993). Animal
care and experiments were conducted according to protocols ap-
proved by the Animal Care and Use Committee of Harvard Medical
School and the CBR Institute for Biomedical Research. 8- to 12-
week-old homozygous mutant mice and age-matched control
mice of the C57B/6 background (Charles River Laboratories) and
mice carrying the Xid mutation on the CBA background (Jackson
Laboratories) were analyzed. IgHEL mice (MD4 substrain) and the
Cre-deleter strain, both on the C57BL/6 background, were previ-
ously described (Goodnow et al., 1988; Schwenk et al., 1995).
Flow Cytometry
Four-color flow cytometric analysis of bone marrow, spleen, and
peritoneal lavage was performed employing a BD FACS Calibur.
Data were analyzed with the Flow Jo analysis program (Tristar
Inc.) and depicted as 2% probability contour plots or histograms
displaying fluorescence intensity (FI) plotted against cell numbers/
FI interval with a total of 256 intervals per parameter. All antibody
conjugates used in this study were purchased from BD Pharmingen,
with the exception of IgM Fab conjugates (Jackson Immunore-
search) and rabbit polyclonal BAFF-R antibody (Y. Sasaki).
BrdU Labeling
Mice were fed with BrdU (Sigma-Aldrich) in the drinking water
(0.8 mg/ml) for 2 weeks. BrdU incorporation into splenic B cells
was analyzed with reagents from BD Pharmingen according to man-
ufacturer’s instructions.
Immunizations, ELISA, ELIspots
Mice were immunized by intraperitoneal injection of NP-Ficoll (4-Hy-
droxy-3-nitrophenylacetyl-AECM-Ficoll) and alum precipitated NP-
CGG (4-Hydroxy-3-nitrophenylacetyl chicken gglobulin) purchased
from Biosearch Technologies. Numbers of NP-specific IgM AFCs
were determined by culturing splenic cells at different cell concen-
trations on NP-BSA-coated PVDF membranes (Pall Corporation)
overnight and subsequent detection of secreted NP-specific IgM
with secondary reagents. Sera were analyzed by ELISA with coating
and detection antibodies generated previously in the laboratory or
purchased from Southern Biotech and Biosearch Technologies
(Kraus et al., 2001).
B Cell Purification
Splenic B cells were purified by depletion of CD43-expressing non-B
cells with anti-CD43 MACS Beads resulting in fractions containing
85%–90% B cells (Miltenyi Biotech). In case of the antigen presenta-
tion assay, splenocytes were also MACS depleted of CD11c-ex-
pressing cells.
Proliferation Assays
To assay for B cell activation and proliferation, purified splenic B
cells were cultured in complete DMEM 10% FCS (Invitrogen) with
anti-IgM F(ab)2 fragments (Jackson Immunoresearch), recombinant
human BAFF (Biogen), CD40 antibody Clone 1C10 (Ebioscience),
IL-4 (R&D), LPS (Sigma Aldrich), and synthesized 20-mer of CpG
DNA. For assessment of DNA content of proliferating B cells, etha-
nol-fixed cultures were treated with RNase A (Sigma-Aldrich) and
stained with propidium iodide (Sigma-Aldrich). Cell divisions were
quantified by labeling B cells with CFSE (Molecular Probes) prior
to culturing, and dead cells were excluded by DNA staining of apo-
ptotic cells with TO-PRO-3 (Molecular Probes).
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To assay for the antigen presentation capacity of B cells, IgHEL
B cells were cocultured with the I-Ab restricted HEL peptide
(aa 74–88)-specific T cell hybridoma line BO4H9 (Shastri et al.,
1986) and with dimeric HEL for 24 hr (Kim et al., 2006). IL-2 secretion
into the supernatants was measured by ELISA.
Cap Formation
For analysis of cap formation of surface IgM, purified B cells, stained
with anti-IgM Fab-FITC (Jackson Immunoresearch) and anti-B220-
PE (BD Pharmingen), were mounted onto cover slips and stimulated
in RPMI 2% FCS at 37C with anti-IgM F(ab)2 fragments (Jackson
Immunoresearch). Images were acquired with a Zeiss immunofluo-
rescence microscope and Slidebook4 Imaging Software (3I) em-
ploying 500 ms exposure times of each field and a 403magnification
lens. The percentage of capped B cells was determined by analyzing
150–300 B220+ cells per time point and genotype.
BCR Internalization Assay
Splenic cells were stimulated in RPMI 2% FCS at 37C with anti-IgM
F(ab)2 fragments, out of which 10% were biotin conjugated (Jackson
Immunoresearch) followed by immediate fixation with 1% formalde-
hyde PBS solution after indicated time points. Surface bound anti-
IgM F(ab)2 was visualized by flow cytometric detection after second-
ary staining with a streptavidin conjugate (BD Pharmingen).
Immunoblots
Purified splenic B cells in RPMI 2% FCS were stimulated with 10 mg
anti-IgM F(ab)2 fragments/10
6 cells and whole-cell lysates prepared
by immediate lysis in 1% NP-40 lysis buffer 1 mM sodium orthova-
nadate, 5 mM sodium pyrophosphate, 10 mM sodium fluoride,
2 mM phenylmethylsulfonyl fluoride, and further protease inhibitors
(Roche) and three freeze and thaw cycles. 10–20 mg protein per lane
was subjected under reducing conditions to a 10% SDS-PAGE (Hoe-
fer) and wet transferred to PVDF membranes (Biorad, Millipore) ac-
cording to manufacturer’s instructions. Immunoblotting antibodies
directed against pSyk, pBLNK Y96, BLNK, pBtk, Btk, pPLCg2,
pIkBa, pERK, ERK, and JNK were obtained from Cell Signaling Tech-
nologies, pJNK from Invitrogen, mAB 4G10 from Upstate, antibodies
specific for b-actin from Sigma, for PLCg2 and IkBa from Santa Cruz,
for pBLNK Y72 and Y84 from A. Chan, and for Iga from J.C. Cambier.
Images shown were either captured with a Fujifilm LAS-3000 imag-
ing system, allowing for digital quantification of signal intensity, or
by Hyperfilm ECL (Amersham).
Calcium Flux
Splenic cells were labeled with Indo-1 (Molecular Probes), and cal-
cium flux of B cells resuspended in 2 3 106 cell/ml RPMI 2% FCS
was assayed by measurement of 405 nm/485 nm emission ratio after
excitation with a 350 nm UV laser on a FACS Vantage flow cytometer
(BD). Data were analyzed with the Flow Jo Analysis program (Tristar
Inc.).
Statistical Analysis
p values were determined by applying Student’s two-tailed t test for
independent samples assuming equal variances on all experimental
data sets.
Supplemental Data
Four Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/1/55/DC1/.
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